226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
102.99%
Net income growth above 1.5x JD's 10.51%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.94%
Negative yoy D&A while JD is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-175.46%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
175.46%
SBC growth of 175.46% while JD is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
61200.19%
Working capital change of 61200.19% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
29.88%
AR growth of 29.88% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-1996.05%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
1027.44%
AP growth of 1027.44% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
18.35%
Growth of 18.35% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-200.99%
Both negative yoy, with JD at -301.39%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
642.09%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
41.71%
CapEx growth of 41.71% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
-102.63%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-27.88%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-52.50%
We reduce yoy sales while JD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
97.93%
Less 'other investing' outflow yoy vs. JD's 248.67%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-144.83%
We reduce yoy invests while JD stands at 230.06%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
31.33%
Debt repayment growth of 31.33% while JD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-197.95%
Negative yoy issuance while JD is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.